Compound ID | 1214
MET-2
Class: Probiotic
| Spectrum of activity: | Gram-positive |
| Details of activity: | C. difficile Infection |
| Institute where first reported: | NuBiyota LLC/ Takeda Pharmaceutical Company Ltd. |
| Highest developmental phase: | Phase 1 |
| Development status: | Active |
| External links: | |
| Citation: | https://www.takeda.com/en-au/what-we-do/our-products/ |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.